1）日本腎移植学会ファクトブック2021. http://www.asas.or.jp/jst/pdf/factbook/factbook2021.pdf2）Mengela M, Sisa B, Haas M, Colvin RB, Halloranb PF, Racusene LC, et al. Banff 2011 meeting report: new conceptsin antibody-mediated rejection. Am J Transplant 2012; 12(3): 563-70.3）Racusen LC, Solez K, Colvin RB, Bonsib SM, Castro MC, Cavallo T, et al. The banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55(2): 713-23.4）Sellarés J, Freitasa DGD, Mengel M, Reeve J, Einecke G, Sis B, et al. Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence. Am J Transplant 2011; 12(2): 388-99.5）Halloran PF, Chang J, Famulski K, Hidalgo LG, Salazar IDR, Lopez MM, et al. Disappearance of T cell-mediated rejection despite continued antibody-mediated rejection in late kidney transplant recipients. J Am Soc Nephrol 2015; 26(7): 1711-20.6）Friedewald JJ, Kurian SM, Heilman RL, Whisenant TC, Poggio ED, Marsh C, et al. Development and clinical validity of a novel blood-based molecular biomarker for subclinical acute rejection following kidney transplant. Am J Transplant 2018; 19(1): 98-109.7）Schrier RW, Wang W, Poole B, Mitra A. Acute renal failure: definitions, diagnosis, pathogenesis, and therapy. J Clin Invest 2004; 114(1): 5-14.8）Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007; 9(6): 654-9.9）Matsuzaki K, Fujita K, Jingushi K, Kawashima A, Ujike T, Nagahara A, et al. MiR-21-5p in urinary extracellular vesicles is a novel biomarker of urothelial carcinoma. Oncotarget 2017; 8(15): 24668-78.10）Hricik DE, Nickerson P, Formica RN, Poggio ED, Rush D, Newell KA, et al. Multicenter validation of urinary CXCL9 as a risk-stratifying biomarker for kidney transplant injury. Am J Transplant 2013; 13(10): 2634-44.11）Goldfarb DA. Urinary-cell mRNA profile and acute cellular rejection in kidney allografts. J Urol 2013; 190(6): 2175-6.12）Afaneh C, Muthukumar T, Lubetzky M, Ding R, Snopkowski C, Sharma VK, et al. Urinary cell levels of mRNA for OX40, OX40L, PD-1, PD-L1, or PD-L2 and acute rejection of human renal allografts. Transplantation 2010; 90(12): 1381-7.13）Bosch TPPVD, Hilbrands LB, Kraaijeveld R, Litjens NHR, Rezaee F, Nieboer D, et al. Pretransplant Numbers of CD16＋ Monocytes as a Novel Biomarker to Predict Acute Rejection After Kidney Transplantation: A Pilot Study. Am J Transplant 2017; 17(10): 2659-67.14）Tajima S, Fu R, Shigematsu T, Noguchi H, Kaku K, Tsuchimoto A, et al. Urinary human epididymis secretory protein 4 as a useful biomarker for subclinical acute rejection three months after kidney transplantation. Int J Mol Sci 2019; 20(19): 4699.59文 献
元のページ ../index.html#73